Do Soleno Therapeutics Inc (NASDAQ: SLNO) Fit In A Value Investing Philosophy?
Currently, there are 31.68M common shares owned by the public and among those 25.93M shares have been available to trade. The company’s stock has a 5-day price change of 4.71% and 20.89% over the past three months. SLNO shares are trading 29.12% year to date (YTD), with the 12-month market performance up to 123.24% higher. […]
